SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?


To: Henry Niman who wrote (29237)9/2/1999 9:55:00 AM
From: Phil Cressman  Read Replies (2) | Respond to of 32384
 
Any idea what was paid for the LGND stock as part of the deal announced? Probably a premium over market price but wonder what. Ligand must now have about the largest number of major pharma's collaborating on various drug canditates. That blue sky potential PLUS their own products now entering or about to enter the marketplace with profitability a year or so away should mean a higher market cap than we see. Short of an absolutely blockbuster announcement however I'm resigned to just holding on for the long term value I feel will come. Wonder if shorts will feel the pinch over this latest validation of their technology.



To: Henry Niman who wrote (29237)9/2/1999 9:59:00 AM
From: Wallace Rivers  Read Replies (1) | Respond to of 32384
 
WOW!!



To: Henry Niman who wrote (29237)9/2/1999 10:02:00 AM
From: SPSEIFERT  Read Replies (1) | Respond to of 32384
 
OT Henry I know you use SI extensively and I need some help. Since SI went to the new format it takes forever to bring screens up. Especially when I go from a bookmarked stock message board back to subject marks to look at a new board. Are you having the same experience and is there anything I can do to improve performance. I bought another 1000 LGND this AM. I am a believer as I have owned since 1994 without selling. When it finally moves I can thank you for all your insight over the years.



To: Henry Niman who wrote (29237)9/2/1999 10:04:00 AM
From: Arthur Radley  Read Replies (2) | Respond to of 32384
 
Nice to see it doing so well in this horrible market. Even my little TTP is holding up well. Maybe all this hype about drug pipelines and mergers will have a positive impact going forward with biotechs.